EPO published international patent application EP4633535A1 titled 'Minimally Invasive Implantable Valve Prosthesis, and Valve Stent for Connecting Artificial Valve Leaflets' filed by RWTH Aachen University. The patent covers prosthetic heart valve technology including the stent design and artificial valve leaflet connection mechanism. The application designates all EU member states and EPC contracting states including Germany, France, Italy, Spain, and the United Kingdom.

For medical device manufacturers developing cardiac valve technologies, this patent publication establishes intellectual property rights that may affect freedom-to-operate analyses. RWTH Aachen University has secured patent protection across 32 designated states covering EU member states and EPC contracting countries. No immediate compliance action is required, but companies should assess whether their valve prosthesis development activities may infringe this newly published patent when it grants.